EUVIMED · CrossrefZeitschrift
Nanomedicine
ISSN 1743-5889 · Informa UK Limited
Neueste Artikel
Drug resistance in castration-resistant prostate cancer and the therapeutic potential of mesoporous polydopamine-based nanoplatforms
Toward drug-driven design of topical ocular liposomes: a critical assessment of formulation decisions and ocular outcomes
Cytokine networks in the tumor microenvironment: nanotherapeutic modulation of immune-cell communication and signaling networks
Nanotechnology-enabled drug delivery for retinoblastoma: formulation strategies, ocular targeting and translational perspectives
Not every gene-targeted therapy is gene therapy: is RNAi considered gene therapy?
When structural sophistication becomes a translational barrier: the complexity trap in DNA nanocarrier design
The role of nanomedicine in infectious diseases of the central nervous system: a narrative review
Preparation of a self-emulsifying nanoemulsion of Salvianolic acid A and its nephroprotective effects on doxorubicin-induced nephropathy
Porous nanofibrous microspheres: synthesis approaches and applications to tissue regeneration
A review of carbon nanodot bio-interactions and safety from cells to animals 2020 to 2025
Evaluation of a bismuth-ellagic acid metal-organic framework for the prophylaxis of inflammatory disorders
Real-world effectiveness of polymeric micellar paclitaxel versus albumin-bound paclitaxel in advanced esophageal squamous cell carcinoma: a retrospective study
Hybrid lipid-coated silver nanoparticles as programmable antimicrobial platforms: balancing silver accessibility, efficacy, and toxicity
Dual-vector nanoengineered mRNA-CRISPR delivery systems for precision gene therapy in choroidal melanoma
Alzheimer’s disease: targeted nanomedicine to mitigate neuroinflammation
Cuproptosis-based nanomedicine targeting metabolic vulnerabilities for cancer therapy
Multimodal nanoengineered scaffolds as regenerative microenvironment orchestrators: coupling mechanical, bioelectrical, immunological, and spatiotemporal therapeutic cues
Evolving skin cancer therapeutics: molecular and genetic drivers, immunotherapy challenges, and advances in nanogel-based nanomedicine
Cardiac nanomedicine for ischemic injury and remodeling: imaging and therapy
mRNA-based nanomedicine for diabetic wound repair: advances in LNP delivery, immune modulation, and regenerative pathways
Engineered SHED-EVs delivering FtMt siRNA rescue mitophagy and bone formation in smoking-related osteoporosis
Opportunities and challenges of nanomedicine for muscular dystrophy
Macrophage-derived exosomes carrying RAD50 attenuate oxidative DNA damage and p53–p21-dependent S-phase arrest in spermatogenic cells
Sensitizing nanomedicine for platinum-resistant ovarian cancer
Heat-preconditioned MSC-derived exosomal miR‑486‑5p reverses doxorubicin resistance in breast cancer
New approach methodologies to model the female reproductive tract: advances and opportunities for nanomedicine
Neuroprotective effects of lithium and caffeic acid co-loaded liposomes in diabetes-induced Alzheimer’s disease: association with GSK-3β and β-catenin
The Italian Nanomedicine Platform (INP): national integration within the European nanomedicine ecosystem
Multifunctional nanoplatforms nanomedicine–device combination products: a translational maturity framework spanning nanocoated implants, theranostic platforms, wearable nanosensors, drug-eluting devices, intratumoral nanoparticle injections, and inorganic hybrid nanoplatforms
CRISPR-Cas9‑based lipid nanocarriers for advanced therapy of urinary bladder cancer
EUVIMED